Demant A/S (OTCMKTS:WILYY - Get Free Report)'s share price shot up 2.7% on Tuesday . The company traded as high as $19.37 and last traded at $19.37. 142 shares changed hands during mid-day trading, an increase of 6% from the average session volume of 134 shares. The stock had previously closed at $18.87.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. UBS Group upgraded shares of Demant A/S to a "strong-buy" rating in a report on Wednesday, August 28th. Hsbc Global Res upgraded shares of Demant A/S to a "hold" rating in a report on Friday, September 13th. Finally, The Goldman Sachs Group upgraded shares of Demant A/S to a "strong-buy" rating in a report on Monday, October 21st.
Check Out Our Latest Research Report on Demant A/S
Demant A/S Price Performance
The firm's fifty day moving average is $19.18 and its 200-day moving average is $20.59.
Demant A/S Company Profile
(
Get Free Report)
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Featured Stories
Before you consider Demant A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Demant A/S wasn't on the list.
While Demant A/S currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
